{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:43:44Z","timestamp":1793331824794,"version":"4.5.0"},"publisher-location":"Singapore","reference-count":59,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811388705","type":"print"},{"value":"9789811388712","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-13-8871-2_3","type":"book-chapter","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T07:02:58Z","timestamp":1565334178000},"page":"37-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Current Opinion for Hypertension in Renal Fibrosis"],"prefix":"10.1007","author":[{"given":"Hai-Jian","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/hr.2009.217","volume":"33","author":"EH Bae","year":"2010","unstructured":"Bae EH, Kim IJ, Ma SK, Kim SW (2010) Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats. Hypertens Res 33:255\u2013262","journal-title":"Hypertens Res"},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1097\/01.ASN.0000143721.71748.30","volume":"15","author":"JL Bascands","year":"2004","unstructured":"Bascands JL, Schanstra JP (2004) Bradykinin and renal fibrosis: have we ACE\u2019d it? J Am Soc Nephrol 15:2504\u20132506","journal-title":"J Am Soc Nephrol"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tcb.2008.05.005","volume":"18","author":"A Cano","year":"2008","unstructured":"Cano A, Nieto MA (2008) Non-coding RNAs take centre stage in epithelial- to- mesenchymal transition. Trends Cell Biol 18:357\u2013359","journal-title":"Trends Cell Biol"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.0959-9673.2004.00376.x","volume":"85","author":"C Chatziantoniou","year":"2004","unstructured":"Chatziantoniou C, Boffa JJ, Tharaux PL, Flamant M, Ronco P, Dussaule JC (2004) Progression and regression in renal vascular and glomerular fibrosis. Int J Exp Pathol 85:1\u201311","journal-title":"Int J Exp Pathol"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrneph.2014.31","volume":"10","author":"AE Decleves","year":"2014","unstructured":"Decleves AE, Sharma K (2014) Novel targets of antifibrotic and anti-inflammatory treatment in CKD. Nat Rev Nephrol 10:257\u2013267","journal-title":"Nat Rev Nephrol"},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1365-2613.2011.00760.x","volume":"92","author":"JC Dussaule","year":"2011","unstructured":"Dussaule JC, Guerrot D, Huby AC, Chadjichristos C, Shweke N, Boffa JJ et al (2011) The role of cell plasticity in progression and reversal of renal fibrosis. Int J Exp Pathol 92:151\u2013157","journal-title":"Int J Exp Pathol"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1357-2725(96)00119-7","volume":"29","author":"AM Nahas el","year":"1997","unstructured":"el Nahas AM, Muchaneta-Kubara EC, Essawy M, Soylemezoglu O (1997) Renal fibrosis: insights into pathogenesis and treatment. Int J Biochem Cell Biol 29:55\u201362","journal-title":"Int J Biochem Cell Biol"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1046\/j.1523-1755.2001.059002804.x","volume":"59","author":"AB Fogo","year":"2001","unstructured":"Fogo AB (2001a) Progression and potential regression of glomerulosclerosis. Kidney Int 59:804\u2013819","journal-title":"Kidney Int"},{"key":"3_CR9","first-page":"69","volume":"31","author":"AB Fogo","year":"2001","unstructured":"Fogo AB (2001b) Renal fibrosis and the renin-angiotensin system. Adv Nephrol Necker Hosp 31:69\u201387","journal-title":"Adv Nephrol Necker Hosp"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"R251","DOI":"10.1152\/ajpregu.00645.2006","volume":"293","author":"M Franco","year":"2007","unstructured":"Franco M, Martinez F, Quiroz Y, Galicia O, Bautista R, Johnson RJ et al (2007) Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt- sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 293:R251\u2013R256","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"3_CR11","first-page":"109","volume":"3","author":"SB Ghaderian","year":"2014","unstructured":"Ghaderian SB, Beladi-Mousavi SS (2014) The role of diabetes mellitus and hypertension in chronic kidney disease. J Renal Inj Prev 3:109\u2013110","journal-title":"J Renal Inj Prev"},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"F473","DOI":"10.1152\/ajprenal.00503.2013","volume":"306","author":"BM Grabias","year":"2014","unstructured":"Grabias BM, Konstantopoulos K (2014) The physical basis of renal fibrosis: effects of altered hydrodynamic forces on kidney homeostasis. Am J Physiol Renal Physiol 306:F473\u2013F485","journal-title":"Am J Physiol Renal Physiol"},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev.med.57.121304.131342","volume":"57","author":"RC Harris","year":"2006","unstructured":"Harris RC, Neilson EG (2006) Toward a unified theory of renal progression. Annu Rev Med 57:365\u2013380","journal-title":"Annu Rev Med"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1517\/14656566.2010.485612","volume":"11","author":"PD Hart","year":"2010","unstructured":"Hart PD, Bakris GL (2010) Hypertensive nephropathy: prevention and treatment recommendations. Expert Opin Pharmacother 11:2675\u20132686","journal-title":"Expert Opin Pharmacother"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1161\/CIRCRESAHA.112.277475","volume":"111","author":"SC Harwani","year":"2012","unstructured":"Harwani SC, Chapleau MW, Legge KL, Ballas ZK, Abboud FM (2012) Neurohormonal modulation of the innate immune system is proinflammatory in the prehypertensive spontaneously hypertensive rat, a genetic model of essential hypertension. Circ Res 111:1190\u20131197","journal-title":"Circ Res"},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00109-016-1451-y","volume":"94","author":"T He","year":"2016","unstructured":"He T, Xiong J, Nie L, Yu Y, Guan X, Xu X et al (2016) Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK\/NOX4\/ROS pathway. J Mol Med (Berl) 94:1359\u20131371","journal-title":"J Mol Med (Berl)"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/CS20060342","volume":"112","author":"S Higuchi","year":"2007","unstructured":"Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S (2007) Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 112:417\u2013428","journal-title":"Clin Sci (Lond)"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1172\/JCI0215518","volume":"110","author":"M Iwano","year":"2002","unstructured":"Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341\u2013350","journal-title":"J Clin Invest"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1161\/HYPERTENSIONAHA.111.183301","volume":"59","author":"BL Jennings","year":"2012","unstructured":"Jennings BL, Anderson LJ, Estes AM, Yaghini FA, Fang XR, Porter J et al (2012) Cytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice. Hypertension 59:348\u2013354","journal-title":"Hypertension"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1161\/HYPERTENSIONAHA.108.111229","volume":"52","author":"Z Jia","year":"2008","unstructured":"Jia Z, Guo X, Zhang H, Wang MH, Dong Z, Yang T (2008) Microsomal prostaglandin synthase-1-derived prostaglandin E2 protects against angiotensin II-induced hypertension via inhibition of oxidative stress. Hypertension 52:952\u2013959","journal-title":"Hypertension"},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/ajh\/hpv083","volume":"29","author":"NS Khan","year":"2016","unstructured":"Khan NS, Song CY, Thirunavukkarasu S, Fang XR, Bonventre JV, Malik KU (2016) Cytosolic phospholipase A2\u03b1 is essential for renal dysfunction and end-organ damage associated with angiotensin II-induced hypertension. Am J Hypertens 29:258\u2013265","journal-title":"Am J Hypertens"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1046\/j.1523-1755.2000.07509.x","volume":"75","author":"S Klahr","year":"2000","unstructured":"Klahr S, Morrissey JJ (2000) The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int Suppl 75:S7\u201314","journal-title":"Kidney Int Suppl"},{"key":"3_CR23","doi-asserted-by":"publisher","first-page":"F861","DOI":"10.1152\/ajprenal.00362.2001","volume":"283","author":"S Klahr","year":"2002","unstructured":"Klahr S, Morrissey J (2002) Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283:F861\u2013F875","journal-title":"Am J Physiol Renal Physiol"},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"e000103","DOI":"10.1161\/JAHA.113.000103","volume":"2","author":"H Kusunoki","year":"2013","unstructured":"Kusunoki H, Taniyama Y, Rakugi H, Morishita R (2013) Cardiac and renal protective effects of irbesartan via peroxisome proliferator- activated receptorgamma- hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension. J Am Heart Assoc 2:e000103","journal-title":"J Am Heart Assoc"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.trsl.2014.07.010","volume":"165","author":"SY Lee","year":"2015","unstructured":"Lee SY, Kim SI, Choi ME (2015) Therapeutic targets for treating fibrotic kidney diseases. Transl Res 165:512\u2013530","journal-title":"Transl Res"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/HYPERTENSIONAHA.108.112706","volume":"52","author":"TD Liao","year":"2008","unstructured":"Liao TD, Yang XP, Liu YH, Shesely EG, Cavasin MA, Kuziel WA et al (2008) Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension. Hypertension 52:256\u2013263","journal-title":"Hypertension"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1161\/HYPERTENSIONAHA.109.144428","volume":"55","author":"Y Liu","year":"2010","unstructured":"Liu Y, Taylor NE, Lu L, Usa K, Cowley AW Jr, Ferreri NR et al (2010) Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension 55:974\u2013982","journal-title":"Hypertension"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000045886","volume":"87","author":"DM Lombardi","year":"2001","unstructured":"Lombardi DM, Viswanathan M, Vio CP, Saavedra JM, Schwartz SM, Johnson RJ (2001) Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent. Nephron 87:66\u201374","journal-title":"Nephron"},{"key":"3_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fphys.2018.00105","volume":"9","author":"W Lv","year":"2018","unstructured":"Lv W, Booz GW, Fan F, Wang Y, Roman RJ (2018) Oxidative stress and renal fibrosis: recent insights for the development of novel therapeutic strategies. Front Physiol 9:105","journal-title":"Front Physiol"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1681\/ASN.2011121144","volume":"23","author":"D Macconi","year":"2012","unstructured":"Macconi D, Tomasoni S, Romagnani P, Trionfini P, Sangalli F, Mazzinghi B et al (2012) MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition. J Am Soc Nephrol 23:1496\u20131505","journal-title":"J Am Soc Nephrol"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000086411","volume":"25","author":"RD Manning Jr","year":"2005","unstructured":"Manning RD Jr, Tian N, Meng S (2005) Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol 25:311\u2013317","journal-title":"Am J Nephrol"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/HYPERTENSIONAHA.112.199265","volume":"60","author":"L Marko","year":"2012","unstructured":"Marko L, Kvakan H, Park JK, Qadri F, Spallek B, Binger KJ et al (2012) Interferon- gamma signaling inhibition ameliorates angiotensin II- induced cardiac damage. Hypertension 60:1430\u20131436","journal-title":"Hypertension"},{"key":"3_CR33","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.mehy.2004.11.048","volume":"67","author":"MF McCarty","year":"2006","unstructured":"McCarty MF (2006) Adjuvant strategies for prevention of glomerulosclerosis. Med Hypotheses 67:1277\u20131296","journal-title":"Med Hypotheses"},{"key":"3_CR34","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.116.303697","volume":"116","author":"WG McMaster","year":"2015","unstructured":"McMaster WG, Kirabo A, Madhur MS, Harrison DG (2015) Inflammation, immunity, and hypertensive end- organ damage. Circ Res 116:1022\u20131033","journal-title":"Circ Res"},{"key":"3_CR35","doi-asserted-by":"publisher","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","volume":"292","author":"PK Mehta","year":"2007","unstructured":"Mehta PK, Griendling KK (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292:C82\u2013C97","journal-title":"Am J Physiol Cell Physiol"},{"key":"3_CR36","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.semnephrol.2004.04.007","volume":"24","author":"PS Modlinger","year":"2004","unstructured":"Modlinger PS, Wilcox CS, Aslam S (2004) Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol 24:354\u2013365","journal-title":"Semin Nephrol"},{"key":"3_CR37","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/S0002-9440(10)64445-8","volume":"161","author":"DN Muller","year":"2002","unstructured":"Muller DN, Shagdarsuren E, Park JK, Dechend R, Mervaala E, Hampich F et al (2002) Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol 161:1679\u20131693","journal-title":"Am J Pathol"},{"key":"3_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000481730","volume":"3","author":"F Petrillo","year":"2017","unstructured":"Petrillo F, Iervolino A, Zacchia M, Simeoni A, Masella C, Capolongo G et al (2017) MicroRNAs in renal diseases: a potential novel therapeutic target. Kidney Dis (Basel) 3:111\u2013119","journal-title":"Kidney Dis (Basel)"},{"key":"3_CR39","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1172\/JCI27699","volume":"116","author":"G Remuzzi","year":"2006","unstructured":"Remuzzi G, Benigni A, Remuzzi A (2006) Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116:288\u2013296","journal-title":"J Clin Invest"},{"key":"3_CR40","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1007\/s11095-008-9636-x","volume":"25","author":"R Rodrigues-Diez","year":"2008","unstructured":"Rodrigues-Diez R, Carvajal-Gonzalez G, Sanchez-Lopez E, Rodriguez-Vita J, Rodrigues Diez R, Selgas R et al (2008) Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways. Pharm Res 25:2447\u20132461","journal-title":"Pharm Res"},{"key":"3_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/01.mnh.0000203190.34643.d4","volume":"15","author":"M Ruiz-Ortega","year":"2006","unstructured":"Ruiz-Ortega M, Esteban V, Ruperez M, Sanchez-Lopez E, Rodriguez-Vita J, Carvajal G et al (2006a) Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr Opin Nephrol Hypertens 15:159\u2013166","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ndt\/gfi265","volume":"21","author":"M Ruiz-Ortega","year":"2006","unstructured":"Ruiz-Ortega M, Ruperez M, Esteban V, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G et al (2006b) Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 21:16\u201320","journal-title":"Nephrol Dial Transplant"},{"key":"3_CR43","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1681\/ASN.2010040384","volume":"22","author":"C Ruster","year":"2011","unstructured":"Ruster C, Wolf G (2011) Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J Am Soc Nephrol 22:1189\u20131199","journal-title":"J Am Soc Nephrol"},{"key":"3_CR44","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.biocel.2010.03.016","volume":"42","author":"S Saad","year":"2010","unstructured":"Saad S, Stanners SR, Yong R, Tang O, Pollock CA (2010) Notch mediated epithelial to mesenchymal transformation is associated with increased expression of the Snail transcription factor. Int J Biochem Cell Biol 42:1115\u20131122","journal-title":"Int J Biochem Cell Biol"},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/path.2961","volume":"225","author":"L Sun","year":"2011","unstructured":"Sun L, Zhang D, Liu F, Xiang X, Ling G, Xiao L et al (2011) Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192. J Pathol 225:364\u2013377","journal-title":"J Pathol"},{"issue":"suppl 4","key":"3_CR46","doi-asserted-by":"publisher","first-page":"iv72","DOI":"10.1093\/ndt\/gft025","volume":"29","author":"B. Tampe","year":"2013","unstructured":"Tampe B, Zeisberg M (2014) Contribution of genetics and epigenetics to progression of kidney fibrosis. Nephrol Dial Transplant 29(Suppl 4): iv72\u2013iv79","journal-title":"Nephrology Dialysis Transplantation"},{"key":"3_CR47","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1097\/01.hjh.0000249705.42230.73","volume":"24","author":"N Tian","year":"2006","unstructured":"Tian N, Rose RA, Jordan S, Dwyer TM, Hughson MD, Manning RD Jr (2006) N-acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension. J Hypertens 24:2263\u20132270","journal-title":"J Hypertens"},{"key":"3_CR48","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1046\/j.1440-1681.2003.03930.x","volume":"30","author":"RM Touyz","year":"2003","unstructured":"Touyz RM, Tabet F, Schiffrin EL (2003) Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin Exp Pharmacol Physiol 30:860\u2013866","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"3_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrneph.2010.154","volume":"7","author":"S Udani","year":"2011","unstructured":"Udani S, Lazich I, Bakris GL (2011) Epidemiology of hypertensive kidney disease. Nat Rev Nephrol 7:11\u201321","journal-title":"Nat Rev Nephrol"},{"key":"3_CR50","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/ajh.2009.208","volume":"23","author":"G Wang","year":"2010","unstructured":"Wang G, Kwan BC, Lai FM, Choi PC, Chow KM, Li PK et al (2010) Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. Am J Hypertens 23:78\u201384","journal-title":"Am J Hypertens"},{"key":"3_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1590\/1414-431X20133554","volume":"47","author":"Y Wang","year":"2014","unstructured":"Wang Y, Mu JJ, Liu FQ, Ren KY, Xiao HY, Yang Z et al (2014) Salt-induced epithelial-to-mesenchymal transition in Dahl salt-sensitive rats is dependent on elevated blood pressure. Braz J Med Biol Res 47:223\u2013230","journal-title":"Braz J Med Biol Res"},{"key":"3_CR52","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/iub.1174","volume":"65","author":"Q Wei","year":"2013","unstructured":"Wei Q, Mi QS, Dong Z (2013) The regulation and function of microRNAs in kidney diseases. IUBMB Life 65:602\u2013614","journal-title":"IUBMB Life"},{"key":"3_CR53","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1038\/sj.ki.5001846","volume":"70","author":"G Wolf","year":"2006","unstructured":"Wolf G (2006) Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int 70:1914\u20131919","journal-title":"Kidney Int"},{"key":"3_CR54","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/ajh\/hpt268","volume":"27","author":"S Zambrano","year":"2014","unstructured":"Zambrano S, Blanca AJ, Ruiz-Armenta MV, Miguel-Carrasco JL, Arevalo M, Mate A et al (2014) l-carnitine attenuates the development of kidney fibrosis in hypertensive rats by upregulating PPAR-gamma. Am J Hypertens 27:460\u2013470","journal-title":"Am J Hypertens"},{"key":"3_CR55","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/HYPERTENSIONAHA.111.173328","volume":"59","author":"W Zhang","year":"2012","unstructured":"Zhang W, Wang W, Yu H, Zhang Y, Dai Y, Ning C et al (2012) Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage. Hypertension 59:136\u2013144","journal-title":"Hypertension"},{"key":"3_CR56","doi-asserted-by":"publisher","first-page":"e0142456","DOI":"10.1371\/journal.pone.0142456","volume":"10","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Peng W, Ao X, Dai H, Yuan L, Huang X et al (2015) TAK-242, a toll-like receptor 4 antagonist, protects against aldosterone-induced cardiac and renal injury. PLoS ONE 10:e0142456","journal-title":"PLoS ONE"},{"key":"3_CR57","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1159\/000115289","volume":"28","author":"W Zhao","year":"2008","unstructured":"Zhao W, Chen SS, Chen Y, Ahokas RA, Sun Y (2008) Kidney fibrosis in hypertensive rats: role of oxidative stress. Am J Nephrol 28:548\u2013554","journal-title":"Am J Nephrol"},{"key":"3_CR58","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.redox.2016.12.031","volume":"11","author":"B Zhou","year":"2017","unstructured":"Zhou B, Mu J, Gong Y, Lu C, Zhao Y, He T et al (2017) Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-beta-mediated Nox4 expression. Redox Biol 11:390\u2013402","journal-title":"Redox Biol"},{"key":"3_CR59","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.bbadis.2017.12.028","volume":"1864","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Yu J, Liu J, Cao R, Su W, Li S et al (2018) Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice. Biochim Biophys Acta 1864:860\u2013870","journal-title":"Biochim Biophys Acta"}],"container-title":["Advances in Experimental Medicine and Biology","Renal Fibrosis: Mechanisms and Therapies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-8871-2_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T07:03:19Z","timestamp":1565334199000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-13-8871-2_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789811388705","9789811388712"],"references-count":59,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-8871-2_3","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"9 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}